Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Holders of 5% or more of ITRM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Iterum Therapeutics plc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Iterum Therapeutics plc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Iterum Therapeutics plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 20255:36 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%1.45M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 12, 2021 | New Leaf Venture Management III, L.L.C. | 13D/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Sarissa Capital Management LP | 13D/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Sabby Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 10, 2021 | Advent Life Sciences LLP | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Pivotal bioVenture Partners Fund I, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2021 | Canaan X L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 29, 2021 | Intracoastal Capital, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Iterum Therapeutics plc shares.
No Form 144 notices for Iterum Therapeutics plc are on file.